Navigation Links
CRH Medical Corporation opens Center in Dallas
Date:5/9/2008

VANCOUVER, May 9 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that it has opened a Center for Colorectal Health in Dallas TX. This Center is the Company's first in the Dallas area, one of many new markets that CRH has targeted for expansion. The opening of the Dallas location represents the 5th new Center opened in 2008 bringing the Company's total number of Centers to 13.

According to the National Institute of Health, the prevalence rate of hemorrhoids in the US is about 4.4% of the population. Approximately 50% of the U.S. population will develop hemorrhoids by age 50. The Company plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking s
'/>"/>

SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medical Mutual of Ohio, CareWorks Build a Healthier Workforce
2. Minority medical students receive support to increase diversity in hematology
3. ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
4. Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters
5. Vail Valley Medical Center Board of Directors Announces Appointment of New President & CEO, John Cassin
6. Select Medical Corporation to Announce First Quarter Results on Thursday, May 15
7. Boston Medical Center/Boston University School of Medicine researcher receives award
8. Prisoner HIV program leads to continuum of medical care after release
9. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
10. Medical research is essential to improving the economy and bettering lives
11. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...re-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO ), ...ray of,light-based aesthetic treatment systems, to... from the Korea Food & Drug Administration (KFDA),...removal of pigmented,lesions., Introduced in the ...ynosure flagship product approved for marketing in...
(Date:5/9/2008)...wire-USNewswire/ -- International,Rescue Committee...d four,additional teams are on standby for deploym...le outbreak of water-borne diseases in cyclone-rav...d in the villages I assessed today and,the survivo...r," says the,IRC,s emergency coordinator, Gordon B...
(Date:5/9/2008)...e-USNewswire/ -- Metaverse developer,Simuality LLC...able human,suffering in Myanmar in the wake of Cyc...eloped and are being placed in high-traffic locati...dination being arranged via the,Simuality welcome ...ondlife/Simuality/106/83/41 )., In addition, link...
(Date:5/9/2008)...ne wards off fusarium wilt on leaves , ,...ed approach to helping tomatoes fight a fungus tha...sts. , In agriculture, there,s an ongoing battl...lve along with their host plant,s immune system, a...ne way to increase protection is through disease r...
Breaking Medicine News(10 mins):Health News:Cynosure's Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval 2Health News:Cynosure's Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval 3Health News:International Rescue Committee Mobilizes More Emergency Teams for Myanmar; Warns of Massive Health Disaster Unless Aid Reaches Cyclone Survivors Fast 2
...t was found that transferring growth factor genes ...ance.// In angina, the blood supply to the heart i...the body tries to compensate by growing new blood ...some unknown reason, this process, known as angiog...
...85, is a leading developer of an oxygen-carrying b...y blood substitute undergoing clinical trials that...sidered a substitute for acute blood loss in traum...ss used to manufacture the blood substitute, essen...
...eating in certain susceptible individuals. Researc... at the factors that make some people// susceptibl...nificant symptom. In a new study, they find that t...h lack of sunshine encouraging more eating. This ...
...ersity at Buffalo School of Dental Medicine ,they ...ray// may serve as an accurate early-warning syste...e study was ushered in a population with a high in...study move us closer to the use of panoramic denta...
Other Medicine News:
(Date:5/7/2008)... Study to Evaluate Preferred Induction Dosin...-- Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) t...cals, a,division of Wyeth (NYSE: WYE ), has comme...trial of TRU-015 in patients with rheumatoid arthr...armaceuticals is developing,TRU-015, SBI-087 and o...
(Date:5/7/2008)...ASHINGTON, May 7 /- Shire p... biopharmaceutical company, today,announced findin...examine,treatment differences with DAYTRANA(TM) (m...d girls aged 6 to 12 years with Attention Deficit,...he analysis reaffirmed,that DAYTRANA has an establ...
(Date:5/7/2008)...ASHINGTON, May 7 /- Shire p... biopharmaceutical company, presented,today at a m...pivotal trial,results of INTUNIV, a selective alph...once-daily medication, which is being evaluated fo...it Hyperactivity Disorder,(ADHD). The data demonst...
(Date:5/7/2008)...EW BRUNSWICK, N.J., May 7 /...bcast for financial analysts on Friday, May 9,at 4...can Pain Society,s,(APS) annual meeting in Tampa, ...igational tapentadol immediate release (IR), a nov...ted for the first time at APS., A pre-recorded We...
Breaking Medicine Technology:Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 1Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 2Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 3Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 4Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 5Ortho Biotech Statement on U S Food and Drug Administration Oncologic Drugs Advisory Committee Vote 1518 6Radioimmunotherapy After Chemo Safe for Common Lymphoma 14354 1Radioimmunotherapy After Chemo Safe for Common Lymphoma 14354 2Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 1Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 2Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 3Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 4Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 5Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 6Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 7Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill Rom and Batesville Casket 14352 8Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 1Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 3Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 4Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 5
...E)--Jun 4, 2007 - Researchers at the,Stanford Univ...h,taken by human neural stem cells that were trans...d that the cells successfully,navigate toward area...niscule particles of iron inside,stem cells to act...e imaging. With the ability to monitor where the h...
..., 2007 - MGI Pharma, Inc.,(Nasdaq:MOGN), a biophar...are, today provided highlights of data presentatio...al Oncology (ASCO) Annual,Meeting. Dacogen (decita...s including the presentation of efficacy data in o...) and activity,observed in patients with refractor...
Other Medicine Technology:Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 2Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 3Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10
...CHEM EZ is a small bench top chemistry analyzer th...erformed on reagent strips with results available ...sts per hour. The instrument accepts whole blood s...ipe of a magnetic card. At the conclusion of testi...
Veriteq's Refrigerator and Freezer Monitoring System is a data logger monitoring system for refrigerators and freezers that is easy to install. Using a building's existing ethernet network, Veriteq's
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
Medicine Products: